Development and validation of a salivary tau biomarker in Alzheimer's disease

Hamid Y. Qureshi,Heather Pekeles,Hemant K. Paudel,Hyman M. Schipper,Mervyn Gornistky

White matter and its relationship with cognition in subjective cognitive decline

Alzheimer's Disease Neuroimaging Initiative,Ashleigh F. Parker,Colette M. Smart,Lisa Ohlhauser

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

Betty M. Tijms,Charlotte E. Teunissen,Niki S.M. Schoonenboom,Philip Scheltens,Pieter Jelle Visser,Wiesje M. van der Flier

A proteomic signature for dementia with Lewy bodies

David Julovich,Fan Zhang,James Hall,Leigh A. Johnson,Melissa Edwards,Neill R. Graff-Radford,Otto Pedraza,Sravan Mattevada,Tanis J. Ferman,Tori Como,Zbigniew K. Wszolek

Brain and cognitive correlates of sleep fragmentation in elderly subjects with and without cognitive deficits

Brigitte Landeau,Claire André,Clémence Tomadesso,Florence Mézenge,Francis Eustache,Ga？l Chételat,Pierre Branger,Robin de Flores,Stéphane Rehel,Vincent de la Sayette

Amygdala subnuclei are differentially affected in the different genetic and pathological forms of frontotemporal dementia

David M. Cash,Jason D. Warren,Juan Eugenio Iglesias,Martina Bocchetta

Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment

Hideaki Suzuki,Hiroyasu Akatsu,Hitomi Ito,Kohji Meno,Shan Liu,Tatsumi Korenaga

Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies

Andreas H. Jacobs,IMBI Brain Imaging Working Group,Leonardo Iaccarino

Preanalytical sample handling recommendations for Alzheimer's disease plasma biomarkers

Johann Karl,Richard Batrla,Tobias Bittner

Full exploitation of high dimensionality in brain imaging: The JPND working group statement and findings

Alexander Teumer,Barbara Franke,Charles DeCarli,Claudia L. Satizabal,Gennady V. Roshchupkin,Hans J. Grabe,Katharina Wittfeld,M. Arfan Ikram,Meike W. Vernooij,Mohamad Habes,Neda Jahanshad,Paul M. Thompson,Reinhold Schmidt,Sarah E. Medland,Sudha Seshadri,Wiro Niessen

ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology

Athanasios Dimitriadis,Carolin Koriath,James B. Rowe,Jason D. Warren,John Collinge,Jonathan D. Rohrer,Jonathan M. Schott,Julie Williams,Nick C. Fox,Nicola Denning,Ronald Druyeh,Tammaryn Lashley,William Taylor

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition

Andrew J. Saykin,Ian Sherriff,Judith Romero,Liana G. Apostolova,Noelia Fandos,Pedro Pesini

Clinician-patient communication during the diagnostic workup: The ABIDE project

Annemieke C. Schipper,Ellen M.A. Smets,Femke H. Bouwman,Gerwin Roks,Hilje A. Wind,Ingrid van Maurik,J.Jolijn Kragt,Jacqueline Schuur,Laxsini Murugesu,Leo Boelaarts,Marissa Zwan,Marjolijn S.J. Blaauw,Marleen Kunneman,Niki Schooneboom,Philip Scheltens,Wiesje M. van der Flier

Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study

Clemens R. Scherzer,Fan Zhang,James Hall,Leigh A. Johnson,Melissa Edwards,Yuliya Kuras

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

Bart N. van Berckel,Charlotte E. Teunissen,Femke H. Bouwman,Frank D. Verbraak,Frederik Barkhof,Jacoba A. van de Kreeke,Philip Scheltens

Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers

Constantine G. Lyketsos,Jeannie-Marie Leoutsakos,Paul B. Rosenberg

Genetic determinants of low vitamin B12 levels in Alzheimer's disease risk

Progress update from the hippocampal subfields group

Alison C. Burggren,Ana M. Daugherty,Andrew R. Bender,Arnold Bakker,Attila Keresztes,Craig E.L. Stark,Daniela J. Palombo,David Berron,Elizabeth M. Mulligan,Elliott G. Johnson,Ga？l Chételat,Hippocampal Subfields Group,Jean C. Augustinack,John Pluta,Jordan DeKraker,Joshua K. Lee,Karen M. Rodrigue,Katrin Amunts,Kristen M. Kennedy,Laura E.M. Wisse,Lei Wang,Lorenzo Pasquini,M. Mallar Chakravarty,Margaret L. Schlichting,Marina Boccardi,Markus Werkle-Bergner,Martina Bocchetta,Mirjam I. Geerlings,Naftali Raz,Nanthia A. Suthana,Noa Ofen,Olga Kedo,Paul A. Yushkevich,Prabesh Kanel,Qijing Yu,Renaud La Joie,Ricardo Insausti,Robert S.C. Amaral,Robin de Flores,Song-Lin Ding,Susanne G. Mueller,Trevor A. Steve,Ulman Lindenberger,Valerie A. Carr,Yee Lee Shing,Yushan Huang

Altered expression of insulin-degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E-ε4–associated Alzheimer's disease

Bü？ra Delikkaya,Gina Gallucci,Ming Tong,Natalia Moriel

Tauopathy in basal ganglia involvement is exacerbated in a subset of patients with Alzheimer's disease: The Hisayama study

Hideomi Hamasaki,Hiroyuki Honda,Masahiro Shijo,Satoshi O. Suzuki,Tomoyuki Ohara,Toshiharu Ninomiya,Tsuyoshi Okamoto,Yozo Hatabe

Apolipoprotein E particle size is increased in Alzheimer's disease

Abhik Sen

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease

Anouk den Braber,Bart N. van Berckel,Charlotte E. Teunissen,Elles Konijnenberg,Femke H. Bouwman,Frank D. Verbraak,Frederik Barkhof,Jacoba A. van de Kreeke,Mara ten Kate,Philip Scheltens,Pieter Jelle Visser

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease

Elizabeth Pirraglia,Henrik Zetterberg,Jaime Ramos Cejudo,Je Yeong Sone,Jingyun Chen,Kaj Blennow,Ludovic Debure,Mony J. de Leon,Tracy Butler,Yi Li

Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer's disease

Arthur W. Toga,Giuseppe Barisano,Jeiran Choupan,Meng Law,Nasim Sheikh-Bahaei,Ryan P. Cabeen

Sex-specific incident dementia in patients with central nervous system trauma

Angela Colantonio,Mackenzie Hurst,Michael Escobar

Short height and poor education increase the risk of dementia in Nigerian type 2 diabetic women

Efosa Kenneth Oghagbon

Structural connectivity centrality changes mark the path toward Alzheimer's disease

Antonio Díaz-Parra,David Moratal,John-Paul Taylor,Luis R. Peraza,Oliver Kennion,Roman Bauer

Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia

Charisse N. Winston,Edward J. Goetzl,Fanny M. Elahi,Janice B. Schwartz

APOE ε4, the door to insulin-resistant dyslipidemia and brain fog? A case study

Seth Stoykovich

Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration

Anand Viswanathan,Bonnie Y.K. Lam,Bradley J. MacIntosh,Charles DeCarli,Cheryl R. McCreary,Christopher Chen,Christopher J.M. Scott,David Werring,Dominic Job,Eric Jouvent,Frank Erik de Leeuw,Fran？ois De Guio,G. Bruce Pike,Geert Jan Biessels,Hieab Adams,Jennifer Linn,Joanna M. Wardlaw,Joel Ramirez,Jose Rafael Romero,Lenore J. Launer,Leonardo Pantoni,Lucia Ballerini,M. Arfan Ikram,M. Edip Gurol,Marco Düring,Martin Dichgans,Matthias van Osch,Meike W. Vernooij,Michael Ingrisch,Michael J. Thrippleton,Mukul Sharma,Natalia S. Rost,Perminder S. Sachdev,Rebecca M.E. Steketee,Richard Frayne,Richard H. Swartz,Robert van Oostenbrugge,Rod Corriveau,Sandra E. Black,Sanneke van Rooden,Simon Duchesne,Stefan Ropele,Steven M. Greenberg,Steven Sourbron,Sudha Seshadri,Vincent C.T. Mok,Walter H. Backes,Yael D. Reijmer

Quantifying memory deficits in amnestic mild cognitive impairment

Aina Yá？ez,Antònia Siquier,Guillermo Amer Ferrer,Helena Vico

Brain imaging working group summaries for the European Joint Programme for Neurodegenerative Disease Research

Giovanni B. Frisoni

Retinal ganglion cell–inner plexiform layer thickness is nonlinearly associated with cognitive impairment in the community-dwelling elderly

Jeng-Min Chiou,Min-Kuang Tsai,Ta-Fu Chen,Yao-Lin Liu,Yen-Ching Chen,Yi-Ting Hsieh

What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A？systematic review

Alex McKeown,Amanda Ly,Anders Gustavsson,Anna Ponjoan,Buket ？ztürk,Catherine Reed,Cathie Sudlow,Christin Bexelius,Christoph Jindra,Christophe Bintener,Emilse Roncancio-Diaz,Enrico Fantoni,Helen Baldwin,Isabella F. J？rgensen,Josep Garre-Olmo,Mia Nelson,Michael Smith,Michele H. Potashman,Olin Janssen,Stephanie Vos,the ROADMAP consortium

Subjective cognitive decline, APOE ε4, and incident mild cognitive impairment in men and women

Angela Winkler,Christian Weimar,Heinz Nixdorf Recall Study Investigative Group,Jessica Abramowski,Karl-Heinz J？ckel,Martha Jokisch,Nico Dragano,Raimund Erbel,Sarah Tebrügge,Susanne Moebus

Posttraumatic stress disorder and total amyloid burden and amyloid-β 42/40 ratios in plasma: Results from a pilot study of World Trade Center responders

Benjamin J. Luft,Candace Stewart,Erica Diminich,Evelyn J. Bromet,Mary Sano,Richard Kew,Roman Kotov,Sam Gandy,Xiaohua Yang,Yael Deri

Frontotemporal dementia is the leading cause of “true” A？/T+ profiles defined with Aβ42/40 ratio

Claire Boutoleau-Bretonnière,Claire Paquet,Edith Bigot-Corbel,Elodie Bouaziz-Amar,Emilie Skrobala,Florence Pasquier,Hélène Pouclet-Courtemanche,Julien Dumurgier,Susanna Schraen,Tri-Bao Nguyen

Retinal microvascular features and cognitive change in the Lothian-Birth Cohort 1936

Alex S.F. Doney,Baljean Dhillon,Emanuele Trucco,Fergus N. Doubal,Ian J. Deary,Joanna M. Wardlaw,John M. Starr,Lucia Ballerini,Sarah McGrory,Stuart J. Ritchie,Thomas J. MacGillivray

Added value of amyloid PET in individualized risk predictions for MCI patients

Arno de Wilde,Bart N.M. van Berckel,Femke H. Bouwman,Johannes Berkhof,Laura M. van der Kall,Philip Scheltens,Wiesje M. van der Flier

European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND)

Alexandre Vignaud,Ariane Fillmer,Arturo Cardenas-Blanco,David Berron,Dennis Chan,Esben Petersen,Fawzi Boumezbeur,Geert Jan Biessels,Hartwig Siebner,Isabella Bj？rkman-Burtscher,Itamar Ronen,Jaco Zwanenburg,James B. Rowe,Jeroen Hendrikse,Julio Acosta-Cabronero,Kamil Uludag,Ludovic de Rochefort,Mark E. Ladd,Mark v Buchem,Mauro Costagli,Michel Bottlaender,Michela Tosetti,Oliver Kraff,Oliver Speck,Oskar Hansson,Penny Gowland,Richard Bowtell,Sina Straub,Stuart Clare,Tony Stoecker

Locus coeruleus MRI contrast is reduced in Alzheimer's disease dementia and correlates with CSF Aβ levels

Annika Spottke,Arturo Cardenas-Blanco,Emrah Düzel,Frank Jessen,Ingo Kilimann,Martin Kanowski,Stefan J. Teipel

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

A. Jon Stoessl,Alessandro Tessitore,Alexander Drzezga,Angelo Antonini,Antonio P. Strafella,Axel Rominger,Daniela Berg,Gregor Wenning,Günter U. H？glinger,Hartwig R. Siebner,Irena Rektorová,James B. Rowe,José ángel Pineda-Pardo,Klaus Seppi,Makoto Higuchi,María Cecilia Peralta,María Rodríguez-Oroz,Matej Ondrus,Nico Bohnen,Nicola Pavese,Oury Monchi,Paola Piccini,Peter Nestor,Roberto Ceravolo,Simon Lewis,Stephane Lehericy,Stephane Thobois,Valtteri Kaasinen

Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease

Ding Ding,Li Zheng,Rui Tao,Shuhao Fu,Xiaoniu Liang,Yiqin Xiao,Zhaozeng Lu,Zhen Hong

Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT)

Bas A. de Jong,Daniela Perani,JPND-PETMETPAT Working Group,Klaus L. Leenders,Paul J.H. van Snick,Remco J. Renken,Ronald Boellaard,Sandeep Golla,Sanne K. Meles,Sjoerd Rijnsdorp

Normative data from linear and nonlinear quantile regression in CANTAB: Cognition in mid-to-late life in an epidemiological sample

Angela Winkler,Caroline Skirrow,Christian Weimar,Johannes Streffer,Luc van Nueten,Maarten Timmers,Martha Jokisch,Michael Krams,Noreen Pundt,Philippa Rock,Pradeep J. Nathan,Rosemary A. Abbott

The social functioning in dementia scale (SF-DEM): Exploratory factor analysis and psychometric properties in mild, moderate, and severe dementia

Anna Brown,Gill Livingston,Jessica Budgett,Stephanie Daley,Sube Banerjee,Thomas E. Page

Heritability in frontotemporal tauopathies

Andrew B. McGeachie,Ciara V. McGinley,Glenda M. Halliday,Heather McCann,John B. Kwok,John R. Hodges,Maria G. Spillantini,Olivier Piguet,Shelley L. Forrest

Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries

J. Scott Andrews,Jody Wen,Noam Y. Kirson,Nori R. Mehta,Wenyu Ye

Actual memory as a mediator of the amyloid-subjective cognitive decline relationship

Michelle E. Farrell,William Moore,Xi Chen

Breadth and depth of working memory and executive function compromises in mild cognitive impairment and their relationships to frontal lobe morphometry and functional competence

Amber Sousa,Jesus J. Gomar,Leticia Garcia-Alvarez,Maria P. Garcia-Portilla